Quoin Pharmaceuticals, Ltd. (QNRX) — DEF 14A Filings
All DEF 14A filings from Quoin Pharmaceuticals, Ltd.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Quoin Pharma Sets August 21 Annual Meeting, Board Urges 'FOR' Votes
— Jul 17, 2025 Risk: low
Quoin Pharmaceuticals, Ltd. (QNRX) has filed a Definitive Proxy Statement (DEF 14A) on July 17, 2025, for its Annual General Meeting of Shareholders scheduled f -
Quoin Pharma Files Proxy Statement
— Oct 24, 2024 Risk: low
Quoin Pharmaceuticals, Ltd. filed a Definitive Proxy Statement (DEF 14A) on October 24, 2024, for the fiscal year ending December 5, 2024. The company, formerly -
Quoin Pharmaceuticals to Hold Special General Meeting on March 29, 2024
— Feb 27, 2024 Risk: medium
Quoin Pharmaceuticals, Ltd. (QNRX) filed a Proxy Statement (DEF 14A) with the SEC on February 27, 2024. Quoin Pharmaceuticals Ltd. will hold a Special General M
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX